Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.

Antigona UlndreajMingyue WangSalvia MisaghianLouis PaoneGeorge B SigalMartin StengelinChristopher CampbellLogan R Van NynattenAntoninus SoosaipillaiAtefeh GhorbaniAnu MathewDouglas D FraserEleftherios P DiamandisIoannis Prassas

Published in: Clinical chemistry and laboratory medicine (2022)

Sample collections at longer time points should be considered in future studies, for assessing the possible development of autoantibody responses following infection with SARS-CoV-2.

Keyphrases

sars cov
respiratory syndrome coronavirus
systemic lupus erythematosus
current status
coronavirus disease
early onset
case control
drug induced